DOP054: Vedolizumab in combination with steroids for induction therapy in Crohn’s disease: an exploratory analysis of the GEMINI 2 and GEMINI 3 studiesECCO '18 Vienna
2018
DOP055: Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patientsECCO '18 Vienna
2018
DOP057: ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn’s disease: Summary of the ECCO-EBMT joint reviewECCO '18 Vienna
2018
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn’s diseaseECCO '18 Vienna
2018
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn’s diseaseECCO '18 Vienna
2018
DOP060: Human amnion epithelial cells and their conditioned media reduces intestinal inflammation and fibrosis in a murine model of chronic colitisECCO '18 Vienna
2018
DOP061: Human amnion epithelial cells reduce intestinal inflammation in a 2,4,6-trinitrobenzene sulfonic acid induced model of acute colitisECCO '18 Vienna
2018
DOP062: The anti-MAdCAM antibody SHP647 in Crohn’s disease: Endoscopic effects of induction therapyECCO '18 Vienna
2018
DOP063: Inhibition of tyrosine kinase 2 signalling ameliorates T cell transfer colitisECCO '18 Vienna
2018
DOP064: ECCO expert consensus and topical review on treatment exit strategies in inflammatory bowel diseaseECCO '18 Vienna
2018
DOP065: Long-term cost-effectiveness of tight control for Crohn’s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trialECCO '18 Vienna
2018
DOP068: Crohn’s disease decision aid leads to more patients choosing combination therapy in a cluster randomised controlled trialECCO '18 Vienna
2018
DOP069: Improved quality of care and quality of life for IBD patients using mobile based remote monitoring platform: A randomised control trialECCO '18 Vienna
2018
DOP070: Development and pilot of an index to identify young people with inflammatory bowel disease at risk of psychological morbidityECCO '18 Vienna
2018